Marine-Sourced Anti-Cancer and Cancer Pain Control Agents in Clinical and Late Preclinical Development
出版年份 2014 全文链接
标题
Marine-Sourced Anti-Cancer and Cancer Pain Control Agents in Clinical and Late Preclinical Development
作者
关键词
-
出版物
Marine Drugs
Volume 12, Issue 1, Pages 255-278
出版商
MDPI AG
发表日期
2014-01-15
DOI
10.3390/md12010255
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Conopeptides as novel options for pain management
- (2014) N.L. Daly et al. DRUGS OF THE FUTURE
- New Interfacial Microtubule Inhibitors of Marine Origin, PM050489/PM060184, with Potent Antitumor Activity and a Distinct Mechanism
- (2013) Benet Pera et al. ACS Chemical Biology
- Marine Natural Products and Related Compounds as Anticancer Agents: an Overview of their Clinical Status
- (2013) Karina Petit et al. Anti-Cancer Agents in Medicinal Chemistry
- Sense and nonsense of high-dose cytarabine for acute myeloid leukemia
- (2013) B. Lowenberg BLOOD
- Inhibitory effects of marine-derived DNA-binding anti-tumour tetrahydroisoquinolines on the Fanconi anaemia pathway
- (2013) Sandra Martínez et al. BRITISH JOURNAL OF PHARMACOLOGY
- Spinal actions of ω-conotoxins, CVID, MVIIA and related peptides in a rat neuropathic pain model
- (2013) A Jayamanne et al. BRITISH JOURNAL OF PHARMACOLOGY
- A phase I pharmacokinetic study of PM00104 (Zalypsis®) administered as a 24-h intravenous infusion every 3 weeks in patients with advanced solid tumors
- (2013) J. Capdevila et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Medicinal Chemistry and Chemical Biology of Diketopiperazine-Type Antimicrotubule and Vascular-Disrupting Agents
- (2013) Yoshio Hayashi et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- Synthesis of Tetrodotoxin, a Classic but Still Fascinating Natural Product
- (2013) Toshio Nishikawa et al. CHEMICAL RECORD
- Comparison ofin vitroandin vivobiological effects of trabectedin, lurbinectedin (PM01183) and Zalypsis® (PM00104)
- (2013) Michela Romano et al. INTERNATIONAL JOURNAL OF CANCER
- Takeda's Oncology Discovery Strategy
- (2013) Brian DeSchuytner et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Microbial natural products: molecular blueprints for antitumor drugs
- (2013) Lesley-Ann Giddings et al. JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY
- Isolation and First Total Synthesis of PM050489 and PM060184, Two New Marine Anticancer Compounds
- (2013) María Jesús Martín et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Phase II study of weekly PM00104 (ZALYPSIS®) in patients with pretreated advanced/metastatic endometrial or cervical cancer
- (2013) Lainie P. Martin et al. MEDICAL ONCOLOGY
- DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody-Drug Conjugate, Is a Potential Treatment for Non-Hodgkin Lymphoma
- (2013) D. Li et al. MOLECULAR CANCER THERAPEUTICS
- From micrograms to grams: scale-up synthesis of eribulin mesylate
- (2013) Melvin J. Yu et al. NATURAL PRODUCT REPORTS
- Brentuximab Vedotin: A CD30-Directed Antibody-Cytotoxic Drug Conjugate
- (2013) Ashley M. Newland et al. PHARMACOTHERAPY
- Commercial Manufacture of Halaven®: Chemoselective Transformations En Route to Structurally Complex Macrocyclic Ketones
- (2013) Francis Fang et al. SYNLETT
- First-in-man phase I trial of two schedules of the novel synthetic tetrahydroisoquinoline alkaloid PM00104 (Zalypsis) in patients with advanced solid tumours
- (2012) T A Yap et al. BRITISH JOURNAL OF CANCER
- Phase I study of PM00104 (Zalypsis®) administered as a 1-hour weekly infusion resting every fourth week in patients with advanced solid tumors
- (2012) Christophe Massard et al. INVESTIGATIONAL NEW DRUGS
- Astellas' Drug Discovery Strategy: Focus on Oncology
- (2012) Y. Yanagita et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Intracutaneous and Intravesical Immunotherapy With Keyhole Limpet Hemocyanin Compared With Intravesical Mitomycin in Patients With Non–Muscle-Invasive Bladder Cancer: Results From a Prospective Randomized Phase III Trial
- (2012) Rianne J.M. Lammers et al. JOURNAL OF CLINICAL ONCOLOGY
- The application of genomic and molecular data in the treatment of chronic cancer pain
- (2012) Ali Turabi et al. JOURNAL OF SURGICAL ONCOLOGY
- Bacterial Biosynthesis and Maturation of the Didemnin Anti-cancer Agents
- (2012) Ying Xu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Tetrodotoxin (TTX) as a Therapeutic Agent for Pain
- (2012) Francisco Rafael Nieto et al. Marine Drugs
- Long-term Tumor Regression Induced by an Antibody-Drug Conjugate That Targets 5T4, an Oncofetal Antigen Expressed on Tumor-Initiating Cells
- (2012) P. Sapra et al. MOLECULAR CANCER THERAPEUTICS
- Didemnins, tamandarins and related natural products
- (2012) Jisun Lee et al. NATURAL PRODUCT REPORTS
- Pharmacokinetic Considerations for Antibody Drug Conjugates
- (2012) Kedan Lin et al. PHARMACEUTICAL RESEARCH
- The molecular mystique of tetrodotoxin
- (2012) Edward G. Moczydlowski TOXICON
- On the origins and biosynthesis of tetrodotoxin
- (2011) Rocky Chau et al. AQUATIC TOXICOLOGY
- Impact of Drug Conjugation on Pharmacokinetics and Tissue Distribution of Anti-STEAP1 Antibody–Drug Conjugates in Rats
- (2011) C. Andrew Boswell et al. BIOCONJUGATE CHEMISTRY
- In vitro and in vivo evaluation of select kahalalide F analogs with antitumor and antifungal activities
- (2011) Abbas Gholipour Shilabin et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Selective Overproduction of the Proteasome Inhibitor Salinosporamide A via Precursor Pathway Regulation
- (2011) Anna Lechner et al. CHEMISTRY & BIOLOGY
- A phase I and pharmacokinetic study of plitidepsin in children with advanced solid tumours: An Innovative Therapies for Children with Cancer (ITCC) study
- (2011) Birgit Geoerger et al. EUROPEAN JOURNAL OF CANCER
- In Vitro and In Vivo Responses of Advanced Prostate Tumors to PSMA ADC, an Auristatin-Conjugated Antibody to Prostate-Specific Membrane Antigen
- (2011) X. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Trabectedin and Its C Subunit Modified Analogue PM01183 Attenuate Nucleotide Excision Repair and Show Activity toward Platinum-Resistant Cells
- (2011) D. G. Soares et al. MOLECULAR CANCER THERAPEUTICS
- Phase III Multicenter Clinical Trial of the Sialyl-TN (STn)-Keyhole Limpet Hemocyanin (KLH) Vaccine for Metastatic Breast Cancer
- (2011) D. Miles et al. ONCOLOGIST
- Antibody drug conjugates — Trojan horses in the war on cancer
- (2011) U. Iyer et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- PM01183, a new DNA minor groove covalent binder with potent in vitro and in vivo anti-tumour activity
- (2010) JFM Leal et al. BRITISH JOURNAL OF PHARMACOLOGY
- Targeting apoptosis pathways by natural compounds in cancer: Marine compounds as lead structures and chemical tools for cancer therapy
- (2010) Karin von Schwarzenberg et al. CANCER LETTERS
- The Discovery of Salinosporamide K from the Marine Bacterium “Salinispora pacifica” by Genome Mining Gives Insight into Pathway Evolution
- (2010) Alessandra S. Eustáquio et al. CHEMBIOCHEM
- Glycoprotein Nonmetastatic B Is an Independent Prognostic Indicator of Recurrence and a Novel Therapeutic Target in Breast Cancer
- (2010) A. A. N. Rose et al. CLINICAL CANCER RESEARCH
- Brentuximab vedotin
- (2010) A. Copeland et al. DRUGS OF THE FUTURE
- Brentuximab vedotin: delivering an antimitotic drug to activated lymphoma cells
- (2010) Stephen M Ansell EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Bioinspired Total Synthesis and Human Proteasome Inhibitory Activity of (−)-Salinosporamide A, (−)-Homosalinosporamide A, and Derivatives Obtained via Organonucleophile Promoted Bis-cyclizations
- (2010) Henry Nguyen et al. JOURNAL OF ORGANIC CHEMISTRY
- Marine Antitumor Drugs: Status, Shortfalls and Strategies
- (2010) Ira Bhatnagar et al. Marine Drugs
- Molecular pharmacology and antitumor activity of Zalypsis ® in several human cancer cell lines
- (2009) Juan F.M. Leal et al. BIOCHEMICAL PHARMACOLOGY
- Function-Oriented Biosynthesis of β-Lactone Proteasome Inhibitors inSalinispora tropica
- (2009) Markus Nett et al. JOURNAL OF MEDICINAL CHEMISTRY
- χ-Conopeptide Pharmacophore Development: Toward a Novel Class of Norepinephrine Transporter Inhibitor (Xen2174) for Pain⊥
- (2009) Andreas Brust et al. JOURNAL OF MEDICINAL CHEMISTRY
- Development of Yondelis® (trabectedin, ET-743). A semisynthetic process solves the supply problem
- (2009) Carmen Cuevas et al. NATURAL PRODUCT REPORTS
- Discovery and development of the anticancer agent salinosporamide A (NPI-0052)
- (2008) William Fenical et al. BIOORGANIC & MEDICINAL CHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started